[Concentration of PGE and 13,14-dihydro-15-keto-PGF2 alpha in bronchial asthma during corticotherapy].
D001249:Asthma / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D011448:Prostaglandin Antagonists; D011458:Prostaglandins E / Q000097:blood*; D011460:Prostaglandins F / Q000037:antagonists & inhibitors / Q000097:blood*; D014222:Triamcinolone Acetonide / Q000494:pharmacology* / Q000627:therapeutic use
D011448:Prostaglandin Antagonists; D011458:Prostaglandins E; D011460:Prostaglandins F; D014222:Triamcinolone Acetonide
Stezenie PgE i 13,14 dwuhydro-15-keto PgF2 alpha u chorych z astma oskrzelowa pod wpływem kortykoterapii.